New drugs that enhance cognition in cognitively healthy individuals present difficult public policy challenges. While their use is not inherently unethical, steps must be taken to ensure that they are safe, that they are widely available to promote equality of opportunity, and that individuals are free to decide whether or not to use them.
Author(s): Maxwell J. Mehlman
Volume 82, Issue 3 (pages 483–506)
Published in 2004